Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
21-31 |
SP_7 |
denotes |
SARS-CoV-2 |
T2 |
86-97 |
CHEBI:17865 |
denotes |
α-ketoamide |
T3 |
86-97 |
CHEBI:17865 |
denotes |
α-ketoamide |
T4 |
98-108 |
CHEBI:35222 |
denotes |
inhibitors |
T5 |
98-108 |
CHEBI:35222 |
denotes |
inhibitors |
T6 |
114-118 |
NCBITaxon:11118 |
denotes |
COVI |
T7 |
119-122 |
SP_7 |
denotes |
-19 |
T8 |
142-150 |
SP_7 |
denotes |
SARS-CoV |
T9 |
144-146 |
UBERON:0001004 |
denotes |
RS |
T10 |
150-152 |
SP_7 |
denotes |
-2 |
T11 |
197-201 |
CHEBI:23888 |
denotes |
drug |
T12 |
197-201 |
CHEBI:23888 |
denotes |
drug |
T13 |
215-228 |
NCBITaxon:11118 |
denotes |
coronaviruses |
T14 |
332-342 |
GO:0006412 |
denotes |
translated |
T15 |
352-357 |
NCBITaxon:10239 |
denotes |
viral |
T16 |
412-422 |
SP_7 |
denotes |
SARS-CoV-2 |
T17 |
436-443 |
GO:0032991 |
denotes |
complex |
T18 |
454-463 |
CHEBI:25754 |
denotes |
ketoamide |
T19 |
454-463 |
CHEBI:25754 |
denotes |
ketoamide |
T20 |
464-473 |
CHEBI:35222 |
denotes |
inhibitor |
T21 |
464-473 |
CHEBI:35222 |
denotes |
inhibitor |
T22 |
519-528 |
CHEBI:35222 |
denotes |
inhibitor |
T23 |
519-528 |
CHEBI:35222 |
denotes |
inhibitor |
T24 |
548-553 |
CHEBI:29337 |
denotes |
amide |
T25 |
548-553 |
CHEBI:29337 |
denotes |
amide |
T26 |
579-587 |
CHEBI:38183 |
denotes |
pyridone |
T27 |
579-587 |
CHEBI:38183 |
denotes |
pyridone |
T28 |
625-633 |
CHEBI:36357 |
denotes |
compound |
T29 |
625-633 |
CHEBI:36357 |
denotes |
compound |
T30 |
637-643 |
UBERON:0001969 |
denotes |
plasma |
T31 |
691-699 |
CHEBI:36357 |
denotes |
compound |
T32 |
691-699 |
CHEBI:36357 |
denotes |
compound |
T33 |
714-723 |
CHEBI:35222 |
denotes |
inhibitor |
T34 |
714-723 |
CHEBI:35222 |
denotes |
inhibitor |
T35 |
731-741 |
SP_7 |
denotes |
SARS-CoV-2 |
T36 |
801-810 |
CHEBI:35222 |
denotes |
inhibitor |
T37 |
801-810 |
CHEBI:35222 |
denotes |
inhibitor |
T38 |
832-836 |
UBERON:0002048 |
denotes |
lung |